Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-01

Clinical Trial Update: Tranexamic Acid Versus Placebo to Reduce Perioperative Bleeding After Major Hepatectomy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tranexamic acid vs placebo to reduce perioperative bleeding after major liver resection was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Blood Loss, Surgical | Phase 3 | Status: TERMINATED